Lily E. McMorrow

ORCID: 0000-0003-2823-5859
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • SARS-CoV-2 and COVID-19 Research
  • Systemic Lupus Erythematosus Research
  • Empathy and Medical Education
  • Patient-Provider Communication in Healthcare
  • Heparin-Induced Thrombocytopenia and Thrombosis
  • Systemic Sclerosis and Related Diseases
  • Cardiovascular Health and Risk Factors
  • Viral Infections and Immunology Research
  • COVID-19 and Mental Health
  • Social Media in Health Education
  • Human Health and Disease
  • Primary Care and Health Outcomes
  • Healthcare Systems and Public Health
  • Animal Virus Infections Studies
  • Peripheral Neuropathies and Disorders
  • Immunotherapy and Immune Responses
  • Diabetes Management and Education
  • Optimism, Hope, and Well-being
  • Long-Term Effects of COVID-19
  • Ginkgo biloba and Cashew Applications
  • Dermatological and COVID-19 studies
  • Lipid metabolism and disorders
  • Innovations in Medical Education

Washington University in St. Louis
2021-2023

Patients with chronic inflammatory disease (CID) treated immunosuppressive medications have increased risk for severe COVID-19. Although mRNA-based SARS-CoV-2 vaccination provides protection in immunocompetent persons, immunogenicity immunosuppressed patients CID is unclear.To determine the of vaccines CID.Prospective observational cohort study.Two U.S. referral centers.Volunteer sample adults confirmed eligible early COVID-19 vaccination, including hospital employees any age and older than...

10.7326/m21-1757 article EN Annals of Internal Medicine 2021-08-30

ABSTRACT Background Individuals with chronic inflammatory diseases (CID) are frequently treated immunosuppressive medications that can increase their risk of severe COVID-19. While novel mRNA-based SARS-CoV-2 vaccination platforms provide robust protection in immunocompetent individuals, the immunogenicity CID patients on immunosuppression is not well established. Therefore, determining effectiveness vaccines setting essential to risk-stratify impaired and clinical guidance regarding...

10.1101/2021.04.05.21254656 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2021-04-07

Objective Little is known regarding the reactogenicity and related SARS–CoV‐2 vaccine response in patients with chronic inflammatory disease (CID). Our objective was to characterize adverse event profile of CID following vaccination understand relationship between immunogenicity vaccines. Methods healthy controls eligible receive messenger RNA (mRNA) vaccines participated 3 study visits (pre‐vaccine, after dose 1, 2) which blood clinical data were collected. Assessment events solicited...

10.1002/acr.24894 article EN Arthritis Care & Research 2022-04-12

Effective physician-patient communication is crucial for positive health outcomes patients with chronic diseases. However, current methods of physician education in are often insufficient to help physicians understand how patients' actions influenced by the contexts within which they live. An arts-based participatory theater approach can provide necessary equity framing address this deficiency.The aim study was develop, pilot, and conduct a formative evaluation an interactive skills...

10.2196/40573 article EN cc-by JMIR Formative Research 2023-03-06

Immunocompromised patients with chronic inflammatory disease (CID) may have experienced additional psychosocial burden during the COVID-19 pandemic due to their immunocompromised status. This study was undertaken determine if vaccination would result in improved patient-reported outcomes longitudinally among individuals CID undergoing SARS-CoV-2 regardless of baseline anxiety.

10.1002/acr.25065 article EN Arthritis Care & Research 2022-12-07

Chronic diseases are increasingly responsible for the burden of health outcomes across world. However, there is also increasing recognition that patterns chronic disease (e.g., mortality, quality life, etc.) have inequities race, gender, and socioeconomic groups cannot be solely attributed to these determinants. There a need an organizing framework which centers fundamental causes disparities may better guide future work in centering mechanisms moving beyond acknowledgment disparities. In...

10.3389/fpubh.2022.980731 article EN cc-by Frontiers in Public Health 2022-09-30

<h3>Background</h3> Patients with SLE experience substantial health disparities. Studying the effect of spatial context on outcomes has become a focus in disparities research. The CDC Social Vulnerability Index (SVI) characterizes census tracts by individual dimensions social vulnerability, which create cumulative SVI capable identifying communities where determinants lead to higher levels morbidity and mortality. <h3>Objectives</h3> We sought understand level vulnerability patients reside...

10.1136/annrheumdis-2023-eular.3831 article EN Annals of the Rheumatic Diseases 2023-05-30

<h3>Background</h3> Patients with SLE experience substantial health disparities. Studying the effect of spatial context on outcomes has become a focus in disparities research. The CDC Social Vulnerability Index (SVI) identifies communities where social determinants lead to higher levels morbidity and mortality. We sought understand level vulnerability patients reside determine if specific dimensions were associated disease activity prednisone utilization. <h3>Methods</h3> 272 consented...

10.1136/lupus-2023-kcr.91 article EN cc-by-nc 2023-07-01

<sec> <title>BACKGROUND</title> Effective physician-patient communication is crucial for positive health outcomes patients with chronic diseases. However, current methods of physician education in are often insufficient to help physicians understand how patients’ actions influenced by the contexts within which they live. An arts-based participatory theater approach can provide necessary equity framing address this deficiency. </sec> <title>OBJECTIVE</title> The aim study was develop, pilot,...

10.2196/preprints.40573 preprint EN 2022-06-27
Coming Soon ...